02552

2.0150.98%
RT

Robert Taylor Nelsen

Non-Executive Chairman

Mr. Robert Taylor Nelsen, also known as Bob, M.B.A., is Independent Director of City Therapeutics, Inc. since July 2023. Mr. Nelsen is Director of GreaterGood.com, Inc. from April 2016. He is Director Emeritus of Institute for Systems Biology. He is Director of Ensemble Therapeutics Corporation. He is Co-Founder of Juno Therapeutics, Inc. from March 06, 2018. He joined the Juno Therapeutics, Inc. in August 2013. He was Co-Founder and Director of Juno Therapeutics, Inc. until March 06, 2018. He is Director of GoCampus, Inc. He is Independent Director of NeurogesX, Inc. from July 2000. He joined the NeurogesX, Inc. in July 2000. He is Director of Ares Bioscience GmbH. He is Director of Nura Inc. He is Non-Executive Chairman of Hua Medicine (Shanghai) Ltd. from August 2010. He is Co-Founder & MD of Arch Venture Partners, L.P. He joined the Arch Venture Partners, L.P. in July 1994. He focuses on early-stage, Alternative Energy, Biotech, Pharmaceuticals, Disruptive Innovation, Nanotech. He was Partner of Arch Venture Partners, L.P. He is focused on generating new ideas for disruptive technologies or business models and partnering with founding management teams and entrepreneurs to execute these visions by advancing novel platform technologies with the overarching goal of improving health care and outcomes. He is Director of Sapphire Energy, Inc. He is Director of Kilimanjaro Energy, Inc. He was Independent Director of Vir Biotechnology, Inc. from April 2016 until 2025. He joined the Vir Biotechnology, Inc. in 2016. He is Director of Insitro, Inc. He is Director of Nutcracker Therapeutics, Inc. He is Independent Director of Sana Biotechnology, Inc. from October 2018. He is Member of Advisory Board of Epirus, Inc. He is Board Observer of Arsenal Biosciences, Inc. He is Chairman of the Board of National Resilience, Inc. He is Director of SciNeuro Pharmaceuticals. He is Board Observer of Revolution Healthcare Acquisition Corp. from April 11, 2022. He was Director of Revolution Healthcare Acquisition Corp. until April 11, 2022. He is Senior Advisor of Healthcare of Red Cell Partners, LLC. He focuses on Healthcare. He is Independent Director of Prime Medicine, Inc. from September 2020. He is Member Investment Advisory Board of Autism Impact Fund. He is Member of Executive Advisory Board of Colossal Biosciences Inc. He was Member of Executive Advisory Board of Colossal Biosciences Inc. from 2023 to 2024. He is Director of Altos Labs, Inc. He is Co-Founder & Board Chair of Rippl Care, Inc. He is Director of Paradigm Health, Inc. He is Director of Aera Therapeutics Inc. He is Partner of AE Blue Capital LLC. He is Director of Dispatch Biotherapeutics, Inc. He was Non-Employee Director of Seaport Therapeutics, Inc. since April 2024. He is Director of Xaira Therapeutics, Inc. He was Executive Chairman of Xaira Therapeutics, Inc. He is Advisor of Time BioVentures. He was Director of Adolor Corporation. He was employed at Adolor Corporation from 1994 to May 21, 2008. He was Director of Everyday Learning Corporation. He was Trustee of Fred Hutchinson Cancer Center. He is a director of DNLI. He was Member of Board of Directors of Accelerator Life Science Partners. He was Director of Illumina, Inc. He joined the Illumina, Inc. in June 1998. He was Director of Alnylam Pharmaceuticals, Inc. He was Director of Agios Pharmaceuticals, Inc. He joined the Agios Pharmaceuticals, Inc. in December 2007 until June 2017. He was Director of Receptos, Inc. He was Director of Integrated Diagnostics Inc. He was Independent Director of Denali Therapeutics Inc. from May 2015 to June 02, 2022. He was employed at Denali Therapeutics Inc. until June 02, 2022. He was Director of Fate Therapeutics, Inc. He was employed at Fate Therapeutics, Inc. from September 2007 to June 06, 2014. He was Director of Syros Pharmaceuticals, Inc. from November 2011 to June 2018. He was employed at Syros Pharmaceuticals, Inc. from November 2011 to June 2018. He was Director of Sage Therapeutics, Inc. He was employed at Sage Therapeutics, Inc. from September 2013 to March 15, 2016. He was Director of Bellerophon Therapeutics, Inc. He was employed at Bellerophon Therapeutics, Inc. from February 2014 to December 01, 2015. He was Director of Xcyte Therapies Inc. He joined the Xcyte Therapies Inc. in August 1996. He was Director of Caliper Life Sciences, Inc. He was employed at Caliper Life Sciences, Inc. from September 1995 to February 2004. He was Director of Genomica Corp. He joined the Genomica Corp. in 1997. He was Chairman of Netbot, Inc. He was Director of Optobionics Corporation. He was Director of Prizm Pharmaceuticals. He was Director of Surface Logix, Inc. He was Director of Converge Medical, Inc. He was Director of Elixir Pharmaceuticals, Inc. He was employed at Elixir Pharmaceuticals, Inc. until September 2007. He was Board Observer of Chiasma (Israel) ltd. He was Director, Chairman of Compensation Committee and Chairman of Stock Option Committee of Aptevo Research and Development LLC. He was employed at Aptevo Research and Development LLC until January 2006. He was Board Observer of VLST Corporation. He was Director of Ikaria, Inc. from March 2007. He joined the Ikaria, Inc. in March 2007. He was Director of Kythera Biopharmaceuticals, Inc. He was employed at Kythera Biopharmaceuticals, Inc. from January 2006 to January 05, 2015. He was Independent Director of Karuna Therapeutics, Inc. from August 2018 to June 16, 2021. He was employed at Karuna Therapeutics, Inc. from August 2018 to June 16, 2021. He was Board Observer of Encoded Therapeutics, Inc. until February 2024. He was employed at Encoded Therapeutics, Inc. until February 2024. He was Director of Sienna Biopharmaceuticals, Inc. from October 2015 to October 01, 2018. He was employed at Sienna Biopharmaceuticals, Inc. until October 01, 2018. He was Director of GRAIL, Inc. from January 2016. He was Independent Director of Unity Biotechnology, Inc. from November 2011 to December 2020. He was employed at Unity Biotechnology, Inc. from 2011 to December 2020. He was Senior Manager of ARCH Development Partners, L.L.C. He was member of the board of Celebrate Express, Inc. He was Director of Gossamer Bio, Inc. from January 2018 to December 04, 2018. He was employed at Gossamer Bio, Inc. until December 04, 2018. He was Independent Director of Beam Therapeutics Inc. from June 2017 to May 21, 2021. He was employed at Beam Therapeutics Inc. until May 21, 2021. He was Non-Executive Director of Brii Biosciences Limited from March 24, 2021 to 2024. He was employed at Brii Biosciences Limited until 2024. He was Independent Director of Lyell Immunopharma, Inc. from September 2018 to May 2025. He was employed at Lyell Immunopharma, Inc. until May 2025. He was Director of Maze Therapeutics, Inc. He was Director of ImproveNet, Inc. He was Independent Director of Neumora Therapeutics, Inc. from September 2020 to September 2023. He was employed at Neumora Therapeutics, Inc. until Septemb

Positions